Sionna Therapeutics, Inc.
SION· Nasdaq
Released Nov 10, 2026, before the open
10-Q filed Nov 10, 2026, 41 days after period end · 0001628280-26-072499
| Metric | Q3 2026 | Q3 2025 | Q3 2024 |
|---|---|---|---|
| Net Income | -$32.42M | -$20.28M | -$25.44M |
| EPS Diluted | -$0.72 | -$0.46 | -$5.67 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sionna Therapeutics, Inc. · CIK 2036042 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Sep 30, 2026 · filed Nov 10, 2026 · 41 d after period end
+3.9% from the close of Nov 9, 2026 to the close of Nov 10, 2026, the first after the release.